Targeting Myeloid Epithelial Tyrosine Kinase (MERTK) Receptor in Acute Myeloid Leukemia Using a Novel Antibody Drug Conjugate, Rgx-019-MMAE

被引：1
|
作者：
Tyagi, Anudishi [1 ]
Siddiqui, Maryam
Kurth, Isabel [2 ]
Takeda, Shugaku [2 ]
Eckstrom, Amanda [1 ]
Borgman, Jenny [1 ]
Maiti, Abhishek [3 ]
Battula, Venkata Lokesh [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[2] Inspirna Inc, New York, NY USA
[3] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-175048
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemia
    Kim, Lisa
    Fowler, Brian
    Campbell, Courtney M.
    Slivnick, Jeremy
    Nawaz, Haseeb
    Kaka, Yaquta
    Ruz, Patrick
    Vallakati, Ajay
    Baliga, Ragavendra
    Vasu, Sumithira
    Addison, Daniel
    CARDIO-ONCOLOGY, 2021, 7 (01)
  • [22] An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid Leukemia
    Zheng, Bing
    Yu, Shang-Fan
    del Rosario, Geoffrey
    Leong, Steven R.
    Lee, Genee Y.
    Vij, Rajesh
    Chiu, Cecilia
    Liang, Wei-Ching
    Wu, Yan
    Chalouni, Cecile
    Sadowsky, Jack
    Clark, Vanessa
    Hendricks, Angela
    Poon, Kirsten Achilles
    Chu, Wayne
    Pillow, Thomas
    Schutten, Melissa M.
    Flygare, John
    Polson, Andrew G.
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1358 - 1368
  • [23] Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
    Hong, Chih-Chen
    Lay, Jong-Ding
    Huang, Jhy-Shrian
    Cheng, Ann-Lii
    Tang, Jih-Luh
    Lin, Ming-Tseh
    Lai, Gi-Ming
    Chuang, Shuang-En
    CANCER LETTERS, 2008, 268 (02) : 314 - 324
  • [24] Mer Receptor Tyrosine Kinase Is Over-Expressed In and Contributes to Oncogenesis In Acute Myeloid Leukemia
    Lee-Sherick, Alisa B.
    Eisenman, Kristen M.
    Sather, Susan
    DeRyckere, Deborah
    Schlegel, Jennifer
    Graham, Douglas K.
    BLOOD, 2011, 118 (21) : 607 - 608
  • [25] Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
    A B Lee-Sherick
    K M Eisenman
    S Sather
    A McGranahan
    P M Armistead
    C S McGary
    S A Hunsucker
    J Schlegel
    H Martinson
    C Cannon
    A K Keating
    H S Earp
    X Liang
    D DeRyckere
    D K Graham
    Oncogene, 2016, 35 : 6270 - 6270
  • [26] Targeting drug-resistant acute myeloid leukemia (AML) clone using casein kinase II inhibitor
    Mercer, Katherine
    Duke, Koby
    Rajaiah, Rajesh
    Daniyal, Muhammad
    Qiu, Yi
    Dovat, Sinisa
    Uzun, Yasin
    Zhang, Lijun
    Huang, Suming
    Klink, Morgann
    Gowda, Chandrika
    CANCER RESEARCH, 2023, 83 (07)
  • [27] LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia
    Anami, Yasuaki
    Deng, Mi
    Gui, Xun
    Yamaguchi, Aiko
    Yamazaki, Chisato M.
    Zhang, Ningyan
    Zhang, Chengcheng
    An, Zhiqiang
    Tsuchikama, Kyoji
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2330 - 2339
  • [28] Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia
    Elgamal, Ola A.
    Mehmood, Abeera
    Jeon, Jae Yoon
    Carmichael, Bridget
    Lehman, Amy
    Orwick, Shelley J.
    Truxall, Jean
    Goettl, Virginia M.
    Wasmuth, Ronni
    Tran, Minh
    Mitchell, Shaneice
    Lapalombella, Rosa
    Eathiraj, Sudharshan
    Schwartz, Brian
    Stegmaier, Kimberly
    Baker, Sharyn D.
    Hertlein, Erin
    Byrd, John C.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [29] Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia
    Ola A. Elgamal
    Abeera Mehmood
    Jae Yoon Jeon
    Bridget Carmichael
    Amy Lehman
    Shelley J. Orwick
    Jean Truxall
    Virginia M. Goettl
    Ronni Wasmuth
    Minh Tran
    Shaneice Mitchell
    Rosa Lapalombella
    Sudharshan Eathiraj
    Brian Schwartz
    Kimberly Stegmaier
    Sharyn D. Baker
    Erin Hertlein
    John C. Byrd
    Journal of Hematology & Oncology, 13
  • [30] Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy
    Xu, Weili
    Li, Shuai
    Puan, Kia Joo
    Li, Xueting
    Xu, Caili
    Fan, Jiajun
    Dou, Zihan
    Zhang, Jiquan
    Ju, Dianwen
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 293
12345